0002039280-25-000007.txt : 20251114
0002039280-25-000007.hdr.sgml : 20251114
20251114150229
ACCESSION NUMBER: 0002039280-25-000007
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering
ITEM INFORMATION: Investment Company Act Section 3(c)
ITEM INFORMATION: Section 3(c)(1)
ITEM INFORMATION: Section 3(c)(7)
FILED AS OF DATE: 20251114
DATE AS OF CHANGE: 20251114
EFFECTIVENESS DATE: 20251114
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mission BioCapital VI LP
CENTRAL INDEX KEY: 0002039280
ORGANIZATION NAME:
EIN: 934782451
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-525216
FILM NUMBER: 251484912
BUSINESS ADDRESS:
STREET 1: ONE MAIN STREET, SUITE 1100
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 5085070934
MAIL ADDRESS:
STREET 1: ONE MAIN STREET, SUITE 1100
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0002039280
Mission BioCapital VI LP
ONE MAIN STREET, SUITE 1100
CAMBRIDGE
MA
MASSACHUSETTS
02142
5085070934
DELAWARE
None
None
Limited Partnership
true
2023
General Partner
Mission BioCapital VI GP LLC
One Main Street, Suite 1100
Cambridge
MA
MASSACHUSETTS
02142
Promoter
General Partner of the Issuer
Peter
D.
Parker
One Main Street, Suite 1100
Cambridge
MA
MASSACHUSETTS
02142
Executive Officer
Manager of the General Partner of the Issuer
Pooled Investment Fund
Venture Capital Fund
false
Decline to Disclose
- 06b
- 3C
- 3C.1
- 3C.7
true
0002039280-25-000003
2024-09-30
false
true
false
0
BHA Select Network, LLC
168883
None
None
1 Lincoln St.
29th Floor
Boston
MA
MASSACHUSETTS
02111
All States
false
Indefinite
143750000
Indefinite
false
11
156000
0
The Placement Agent's fees are dependent on the capital raised and will be paid by Mission BioCapital Management Company LLC.
0
The General Partner of an affiliate may be entitled to receive a management fee or carried interest in in accordance with the Issuer's governing documentation, as amended from time to time. The amount of fees cannot be estimated at this time.
false
Mission BioCapital VI LP
/s/ Peter D. Parker
Peter D. Parker
Manager of the General Partner of the Issuer
2025-11-14